Chang, B.-S.; Peng, T.-C.; Wu, Y.-F.; Hsieh, T.-C.; Huang, C.-H.
Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. J. Pers. Med. 2022, 12, 404.
https://doi.org/10.3390/jpm12030404
AMA Style
Chang B-S, Peng T-C, Wu Y-F, Hsieh T-C, Huang C-H.
Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. Journal of Personalized Medicine. 2022; 12(3):404.
https://doi.org/10.3390/jpm12030404
Chicago/Turabian Style
Chang, Bee-Song, Tai-Chu Peng, Yi-Feng Wu, Tsung-Cheng Hsieh, and Chun-Hou Huang.
2022. "Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors" Journal of Personalized Medicine 12, no. 3: 404.
https://doi.org/10.3390/jpm12030404
APA Style
Chang, B.-S., Peng, T.-C., Wu, Y.-F., Hsieh, T.-C., & Huang, C.-H.
(2022). Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. Journal of Personalized Medicine, 12(3), 404.
https://doi.org/10.3390/jpm12030404
